KM Pharmaceutical Non-Registered Executive Kim Jong-gi's Share Count Reduced from 2,930 to 586 Due to Stock Merge, but Stake Remains at 0.01% with No Shareholder Value Impact

The filer is KM Pharmaceutical non-registered executive advisor Kim Jong-gi, whose holding of 2,930 common shares was reduced to 586 shares due to a stock merge effective May 19, 2026.
The stock merge was a face-value consolidation that changed total outstanding shares from 27,887,050 to 5,577,410, but the filer's ownership percentage remained unchanged at 0.01%.
This is simply a report of ownership change due to a stock merger, with no capital movement or new financing involved, resulting in no dilution or enhancement of existing shareholder value.
[AI Summary]KM Pharmaceutical non-registered executive Kim Jong-gi's stock merge report reflects only a mechanical share count adjustment with no change in ownership percentage, and the absence of capital changes makes the impact on shareholder value neutral.